- Home
- IMMX vs MIND Comparison
IMMX vs MIND Comparison
Compare IMMX & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- MIND
- Stock Information
- Founded
- IMMX 2014
- MIND 1987
- Country
- IMMX United States
- MIND United States
- Employees
- IMMX N/A
- MIND N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- MIND Industrial Machinery/Components
- Sector
- IMMX Health Care
- MIND Industrials
- Exchange
- IMMX Nasdaq
- MIND Nasdaq
- Market Cap
- IMMX 61.1M
- MIND 49.6M
- IPO Year
- IMMX 2021
- MIND 1994
- Fundamental
- Price
- IMMX $2.65
- MIND $7.80
- Analyst Decision
- IMMX Strong Buy
- MIND
- Analyst Count
- IMMX 1
- MIND 0
- Target Price
- IMMX $7.00
- MIND N/A
- AVG Volume (30 Days)
- IMMX 137.1K
- MIND 448.2K
- Earning Date
- IMMX 08-11-2025
- MIND 06-10-2025
- Dividend Yield
- IMMX N/A
- MIND N/A
- EPS Growth
- IMMX N/A
- MIND N/A
- EPS
- IMMX N/A
- MIND 2.91
- Revenue
- IMMX N/A
- MIND $45,087,000.00
- Revenue This Year
- IMMX N/A
- MIND $7.27
- Revenue Next Year
- IMMX N/A
- MIND N/A
- P/E Ratio
- IMMX N/A
- MIND $2.68
- Revenue Growth
- IMMX N/A
- MIND 26.68
- 52 Week Low
- IMMX $1.26
- MIND $3.05
- 52 Week High
- IMMX $3.00
- MIND $11.10
- Technical
- Relative Strength Index (RSI)
- IMMX 61.44
- MIND 52.81
- Support Level
- IMMX $2.16
- MIND $7.84
- Resistance Level
- IMMX $2.80
- MIND $8.48
- Average True Range (ATR)
- IMMX 0.17
- MIND 0.66
- MACD
- IMMX 0.04
- MIND -0.06
- Stochastic Oscillator
- IMMX 80.00
- MIND 33.04
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.